Thomas Beder

6PUBLICATIONS
55CO-AUTHORS
Bioinformatic methods developmentHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Immunogenetics (incl. genetic immunology)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 20, 2026
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL.

|Apr 02, 2026
Molecular variants, clonal evolution and clinical relevance in pediatric and adult T-cell lymphoblastic neoplasia.

Sarah Sandmann, Marcel Te Vrugt, Gerrit Randau

|Mar 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Mar 13, 2026
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.

Johanna M Horns, Thomas Beder, Axel Künstner

|Jan 06, 2026
Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia.

Sophie Steinhäuser, Thomas Beder, Emely Hübner

|Nov 24, 2025
Epidemiology and survival of patients with T-cell prolymphocytic leukemia.

Nadine Wolgast, Eric Amelunxen, Lars Fransecky

Pageof 1

Frequent Collaborators

4 joint publications

Lorenz Bastian

3 joint publications

Claudia D Baldus

3 joint publications

Nicola Gökbuget

2 joint publications

Alina M Hartmann